These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 17175232)

  • 21. CD4+CD25+FOXP3+ T regulatory cells reconstitute and accumulate in the bone marrow of patients with multiple myeloma following allogeneic stem cell transplantation.
    Atanackovic D; Cao Y; Luetkens T; Panse J; Faltz C; Arfsten J; Bartels K; Wolschke C; Eiermann T; Zander AR; Fehse B; Bokemeyer C; Kroger N
    Haematologica; 2008 Mar; 93(3):423-30. PubMed ID: 18287134
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-CD25 treatment and FOXP3-positive regulatory T cells in heart transplantation.
    Vlad G; Ho EK; Vasilescu ER; Fan J; Liu Z; Cai JW; Jin Z; Burke E; Deng M; Cadeiras M; Cortesini R; Itescu S; Marboe C; Mancini D; Suciu-Foca N
    Transpl Immunol; 2007 Jul; 18(1):13-21. PubMed ID: 17584597
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased transplant arteriosclerosis in the absence of CCR7 is associated with reduced expression of Foxp3.
    Ensminger SM; Helm SN; Ohl L; Spriewald BM; Abele S; Wollin M; Wood KJ; Weyand M; Förster R
    Transplantation; 2008 Aug; 86(4):590-600. PubMed ID: 18724230
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The presence of Foxp3 expressing T cells within grafts of tolerant human liver transplant recipients.
    Li Y; Zhao X; Cheng D; Haga H; Tsuruyama T; Wood K; Sakaguchi S; Tanaka K; Uemoto S; Koshiba T
    Transplantation; 2008 Dec; 86(12):1837-43. PubMed ID: 19104431
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential expression of T-cell receptor-V region determinants on infiltrating T cells in rejecting and nonrejecting human kidney, liver, and heart allografts.
    Ibrahim S; Dawson DV; Elmohsen MA; Elsamannoudy FA; Sanfilippo F
    Transplant Proc; 1993 Feb; 25(1 Pt 1):80-3. PubMed ID: 8438488
    [No Abstract]   [Full Text] [Related]  

  • 26. Pathologic complete response to neoadjuvant chemotherapy of breast carcinoma is associated with the disappearance of tumor-infiltrating foxp3+ regulatory T cells.
    Ladoire S; Arnould L; Apetoh L; Coudert B; Martin F; Chauffert B; Fumoleau P; Ghiringhelli F
    Clin Cancer Res; 2008 Apr; 14(8):2413-20. PubMed ID: 18413832
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heart allograft acceptance induced by anti-CD3 antibody in high-responder rats: effect on foxp3 and cytokine expression and graft infiltration.
    Lam VW; Taylor CF; Laurence JM; Wang C; Sharland AF; McCaughan GW; Hodgkinson S; Allen RD; Hall BM; Bishop GA
    Transpl Immunol; 2008 Apr; 19(1):20-4. PubMed ID: 18346633
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD8+ Foxp3+ regulatory T cells mediate immunosuppression in prostate cancer.
    Kiniwa Y; Miyahara Y; Wang HY; Peng W; Peng G; Wheeler TM; Thompson TC; Old LJ; Wang RF
    Clin Cancer Res; 2007 Dec; 13(23):6947-58. PubMed ID: 18056169
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer.
    Salama P; Phillips M; Grieu F; Morris M; Zeps N; Joseph D; Platell C; Iacopetta B
    J Clin Oncol; 2009 Jan; 27(2):186-92. PubMed ID: 19064967
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor-infiltrating Foxp3-CD4+CD25+ T cells predict poor survival in renal cell carcinoma.
    Siddiqui SA; Frigola X; Bonne-Annee S; Mercader M; Kuntz SM; Krambeck AE; Sengupta S; Dong H; Cheville JC; Lohse CM; Krco CJ; Webster WS; Leibovich BC; Blute ML; Knutson KL; Kwon ED
    Clin Cancer Res; 2007 Apr; 13(7):2075-81. PubMed ID: 17404089
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting acute allograft rejection by immunotherapy with ex vivo-expanded natural CD4+ CD25+ regulatory T cells.
    Xia G; He J; Zhang Z; Leventhal JR
    Transplantation; 2006 Dec; 82(12):1749-55. PubMed ID: 17198271
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Keratinocyte growth factor improves allogeneic bone marrow engraftment through a CD4+Foxp3+ regulatory T cell-dependent mechanism.
    Bruinsma M; van Soest PL; Leenen PJ; Löwenberg B; Cornelissen JJ; Braakman E
    J Immunol; 2009 Jun; 182(12):7364-9. PubMed ID: 19494258
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Foxp3-expressing regulatory T cells expanded with CD28 superagonist antibody can prevent rat cardiac allograft rejection.
    Kitazawa Y; Fujino M; Sakai T; Azuma H; Kimura H; Isaka Y; Takahara S; Hünig T; Abe R; Li XK
    J Heart Lung Transplant; 2008 Apr; 27(4):362-71. PubMed ID: 18374871
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Presence of tumor-infiltrating lymphocytes is an independent prognostic factor in type I and II endometrial cancer.
    de Jong RA; Leffers N; Boezen HM; ten Hoor KA; van der Zee AG; Hollema H; Nijman HW
    Gynecol Oncol; 2009 Jul; 114(1):105-10. PubMed ID: 19411095
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increase in FOXP3+ regulatory T cells in GVHD skin biopsies is associated with lower disease severity and treatment response.
    Fondi C; Nozzoli C; Benemei S; Baroni G; Saccardi R; Guidi S; Nicoletti P; Bartolozzi B; Pimpinelli N; Santucci M; Bosi A; Massi D
    Biol Blood Marrow Transplant; 2009 Aug; 15(8):938-47. PubMed ID: 19589483
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Demonstration of circulating allergen-specific CD4+CD25highFoxp3+ T-regulatory cells in both nonatopic and atopic individuals.
    Maggi L; Santarlasci V; Liotta F; Frosali F; Angeli R; Cosmi L; Maggi E; Romagnani S; Annunziato F
    J Allergy Clin Immunol; 2007 Aug; 120(2):429-36. PubMed ID: 17604089
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pancreatic islets induce CD4(+) [corrected] CD25(-)Foxp3(+) [corrected] T-cell regulated tolerance to HY-mismatched skin grafts.
    Yoon IH; Choi SE; Kim YH; Yang SH; Park JH; Park CS; Kim Y; Kim JS; Kim SJ; Simpson E; Park CG
    Transplantation; 2008 Nov; 86(10):1352-60. PubMed ID: 19034003
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The regulatory/cytotoxic graft-infiltrating T cells differentiate renal allograft borderline change from acute rejection.
    Grimbert P; Mansour H; Desvaux D; Roudot-Thoraval F; Audard V; Dahan K; Berrehar F; Dehoulle-Poillet C; Farcet JP; Lang P; Le Gouvello S
    Transplantation; 2007 Feb; 83(3):341-6. PubMed ID: 17297410
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Natural killer cells prevent CD28-mediated Foxp3 transcription in CD4+CD25- T lymphocytes.
    Brillard E; Pallandre JR; Chalmers D; Ryffel B; Radlovic A; Seilles E; Rohrlich PS; Pivot X; Tiberghien P; Saas P; Borg C
    Exp Hematol; 2007 Mar; 35(3):416-25. PubMed ID: 17309822
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The graft content of donor T cells expressing gamma delta TCR+ and CD4+foxp3+ predicts the risk of acute graft versus host disease after transplantation of allogeneic peripheral blood stem cells from unrelated donors.
    Pabst C; Schirutschke H; Ehninger G; Bornhäuser M; Platzbecker U
    Clin Cancer Res; 2007 May; 13(10):2916-22. PubMed ID: 17504991
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.